Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients29

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients20

Views

Views
October 20243
November 20240
December 20242
January 20250
February 20250
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom4
 

Top cities views

Views